Objective:

Endoscopic mitral valve surgery is relatively new in mitral valve surgery field. It has potential to become a standard of care for isolated mitral valve surgery. Aim of this study to review experience of endoscopic mitral valve surgery program of 10 years.

Materials: A total of 842 patients underwent from 1 January 2015 to 1 December 2024 mitral valve surgery as a isolated or combined with tricuspid valve surgery through the right mini-thoracotomy. All procedures were performed using endoscopic approach previously described by our team.

Results:

Overall mortality for these series was 1 (0.1233046%). Allover repair rate was 665 (80.90024%). Survival rate at mean 50.5448627 months of follow up mortality rate was 11 (1.306413%). Repair rate on degenerative disease alone was 651 (91.04895%). In ten years of experience 4 new operators were formed. All the resulting newbie surgeons perform at least 30/cases a year. There were non survival differences when stratified for sex, mitral procedure type or high bmi cohort.

Conclusions: Within ten years of endoscopic mitral valve surgery it proved to be safe, reliable, reproduce with excellent results. In our institution it is considered as approach for all-comers.